Advanced Search

Technical Analysis for NBTX - Nanobiotix S.A.

Grade Last Price % Change Price Change
D 14.65 2.02% 0.29
NBTX closed up 2.02 percent on Thursday, July 29, 2021, on 27 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical NBTX trend table...
Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Crossed Above 20 DMA Bullish 2.02%
Pocket Pivot Bullish Swing Setup 2.02%
New 52 Week Closing Low Bearish 7.13%
Lower Bollinger Band Touch Weakness 7.13%
Shooting Star Candlestick Bearish 4.39%
180 Bearish Setup Bearish Swing Setup 4.39%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.39%
Narrow Range Bar Range Contraction 4.39%
Older End-of-Day Signals for NBTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % 7 days ago
Down 1% 7 days ago
Down 5% 9 days ago
Down 3% 9 days ago
Down 2 % 9 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

Is NBTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 20 Nanobiotix Provides Second Quarter Operational and Financial Update
Jul 1 Nanobiotix Starts New NBTXR3 Study In Lung Cancer Patients
Jun 30 Nanobiotix initiates early-stage NBTXR3 lung cancer study
Jun 30 NANOBIOTIX Announces Initiation of New Clinical Study Evaluating NBTXR3 in Lung Cancer
Jun 23 Do Hedge Funds Love Nanobiotix S.A. (NBTX)?
Jun 6 Wall Street Breakfast: The Week Ahead
Jun 4 Nanobiotix's Nanoparticle Technology Shows Tumor-Killing Effect in Early-Stage Head & Neck Cancer
Jun 3 Nanobiotix posts data from NBTXR3 combo cancer study at ASCO
Jun 1 Nanobiotix names Bart Van Rhijn as chief financial officer
May 25 Nanobiotix names Gary Phillips as chairman of supervisory board
See more NBTX news...

Indicators

Indicator Value
52 Week High 21.55
52 Week Low 12.85
Average Volume 2,897
200-Day Moving Average 0.00
50-Day Moving Average 15.15
20-Day Moving Average 14.39
10-Day Moving Average 14.23
Average True Range 0.61
ADX 24.19
+DI 19.53
-DI 28.63
Chandelier Exit (Long, 3 ATRs) 13.44
Chandelier Exit (Short, 3 ATRs) 14.88
Upper Bollinger Bands 15.27
Lower Bollinger Band 13.51
Percent B (%b) 0.65
BandWidth 12.29
MACD Line -0.22
MACD Signal Line -0.26
MACD Histogram 0.0399
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.33
Resistance 3 (R3) 15.25 14.95 15.21
Resistance 2 (R2) 14.95 14.78 14.99 15.17
Resistance 1 (R1) 14.80 14.67 14.88 14.88 15.14
Pivot Point 14.50 14.50 14.54 14.54 14.50
Support 1 (S1) 14.35 14.33 14.43 14.43 14.16
Support 2 (S2) 14.05 14.22 14.09 14.13
Support 3 (S3) 13.90 14.05 14.09
Support 4 (S4) 13.98